Young South African Women Can Adhere to Daily PrEP Regimen as HIV Prevention, Study Finds

A clinical study funded by the National Institutes of Health has found that young, single black women in South Africa adhered to a daily pill regimen to prevent HIV infection—an HIV prevention strategy known as pre-exposure prophylaxis, or PrEP. This finding is the first strong indication that this population at substantial HIV risk could accept and reliably adhere to daily PrEP dosing. Men who have sex with men (MSM) and transgender women (TGW) in New York and Thailand also successfully adhered to daily dosing.
To read the full article, click here.